Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mortimer Poncz

Showing results (121-130 of 165) with videos related to

Pageof 17
Sort By:
Blood Advances|May 1, 2019
Infused factor VIII-expressing platelets or megakaryocytes as a novel therapeutic strategy for hemophilia ARandolph B Lyde, Hyun Sook Ahn, Karen K Vo, et al.
Blood|May 12, 2012
Dynamic antibody-binding properties in the pathogenesis of HITBruce S Sachais, Rustem I Litvinov, Serge V Yarovoi, et al.
Blood|April 23, 2005
PF4/heparin complexes are T cell-dependent antigensShayela Suvarna, Lubica Rauova, Emily K E McCracken, et al.
Blood|October 13, 2018
Polyreactive IgM initiates complement activation by PF4/heparin complexes through the classical pathwaySanjay Khandelwal, Joann Ravi, Lubica Rauova, et al.
Blood|May 3, 2002
Platelet factor 4 binds to low-density lipoprotein receptors and disrupts the endocytic machinery, resulting in retention of low-density lipoprotein on the cell surfaceBruce S Sachais, Alice Kuo, Taher Nassar, et al.
Blood|April 12, 2012
Targeting recombinant thrombomodulin fusion protein to red blood cells provides multifaceted thromboprophylaxisSergei Zaitsev, M Anna Kowalska, Michael Neyman, et al.
ACS Nano|July 9, 2015
Collaborative Enhancement of Endothelial Targeting of Nanocarriers by Modulating Platelet-Endothelial Cell Adhesion Molecule-1/CD31 Epitope EngagementAnn-Marie Chacko, Jingyan Han, Colin F Greineder, et al.
Thrombosis and Haemostasis|March 13, 2019
Epithelial (E)-Cadherin is a Novel Mediator of Platelet Aggregation and Clot StabilityVanessa M Scanlon, Alexandra M Teixeira, Tarun Tyagi, et al.
Blood|April 9, 2015
Comparative analysis of human ex vivo-generated platelets vs megakaryocyte-generated platelets in mice: a cautionary taleYuhuan Wang, Vincent Hayes, Danuta Jarocha, et al.
Blood|April 23, 2010
Sustained thromboprophylaxis mediated by an RBC-targeted pro-urokinase zymogen activated at the site of clot formationSergei Zaitsev, Dirk Spitzer, Juan-Carlos Murciano, et al.
Pageof 17

Showing results (121-130 of 165) with videos related to

Sort By:
Pageof 17
Blood Advances|May 1, 2019
Infused factor VIII-expressing platelets or megakaryocytes as a novel therapeutic strategy for hemophilia ARandolph B Lyde, Hyun Sook Ahn, Karen K Vo, et al.
Blood|May 12, 2012
Dynamic antibody-binding properties in the pathogenesis of HITBruce S Sachais, Rustem I Litvinov, Serge V Yarovoi, et al.
Blood|April 23, 2005
PF4/heparin complexes are T cell-dependent antigensShayela Suvarna, Lubica Rauova, Emily K E McCracken, et al.
Blood|October 13, 2018
Polyreactive IgM initiates complement activation by PF4/heparin complexes through the classical pathwaySanjay Khandelwal, Joann Ravi, Lubica Rauova, et al.
Blood|May 3, 2002
Platelet factor 4 binds to low-density lipoprotein receptors and disrupts the endocytic machinery, resulting in retention of low-density lipoprotein on the cell surfaceBruce S Sachais, Alice Kuo, Taher Nassar, et al.
Blood|April 12, 2012
Targeting recombinant thrombomodulin fusion protein to red blood cells provides multifaceted thromboprophylaxisSergei Zaitsev, M Anna Kowalska, Michael Neyman, et al.
ACS Nano|July 9, 2015
Collaborative Enhancement of Endothelial Targeting of Nanocarriers by Modulating Platelet-Endothelial Cell Adhesion Molecule-1/CD31 Epitope EngagementAnn-Marie Chacko, Jingyan Han, Colin F Greineder, et al.
Thrombosis and Haemostasis|March 13, 2019
Epithelial (E)-Cadherin is a Novel Mediator of Platelet Aggregation and Clot StabilityVanessa M Scanlon, Alexandra M Teixeira, Tarun Tyagi, et al.
Blood|April 9, 2015
Comparative analysis of human ex vivo-generated platelets vs megakaryocyte-generated platelets in mice: a cautionary taleYuhuan Wang, Vincent Hayes, Danuta Jarocha, et al.
Blood|April 23, 2010
Sustained thromboprophylaxis mediated by an RBC-targeted pro-urokinase zymogen activated at the site of clot formationSergei Zaitsev, Dirk Spitzer, Juan-Carlos Murciano, et al.
Pageof 17